Masayasu Okada

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas”.

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas

Frontiers in Oncology(2020)10.3389/fonc.2019.01568

N/A

0DataRank · unranked

44 citations

Manabu Natsumeda, Masayasu Okada, Jun Watanabe, Yoshihiro Tsukamoto, Yu Kanemaru +6 more

Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin

Neuro-Oncology(2022)10.1093/neuonc/noac243

N/A

0DataRank · unranked

19 citations

Junko Murai, Masayasu Okada, Haruhiko Takahashi, Tyler H Findlay, Kristen Malebranche +35 more

SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis

Molecular Cell(2025)10.1016/j.molcel.2025.01.008

N/A

0DataRank · unranked

31 citations

Keiichi Izumikawa, Sota Tate, Sho Isoyama, Mori Masaru, Kohei Fujiwara +22 more